TP15/17/47 Combined Antigen
Antigen material for serology/antibody-reagent development and analytical evaluation involving TP15/17/47. Combined treponemal-antigen material for T. pallidum antibody-serology assay development; component identity should remain source confirmed.
Product Type
Antibodies & Antigens
Sub-Category
Diagnostic Antigens
Platform
CLIA
Application
ALG, INF
Overview
Antigen material for serology/antibody-reagent development and analytical evaluation involving TP15/17/47. Combined treponemal-antigen material for T. pallidum antibody-serology assay development; component identity should remain source confirmed.
Antigen material for serology/antibody-reagent development and analytical evaluation involving TP15/17/47. Combined treponemal-antigen material for T. pallidum antibody-serology assay development; component identity should remain source confirmed. Treponemal tests use T. pallidum-specific antigens, including defined recombinant proteins, to detect treponemal antibodies. Diagnosis requires use within an accepted treponemal/nontreponemal testing algorithm.
Professional Context
Treponemal tests use T. pallidum-specific antigens, including defined recombinant proteins, to detect treponemal antibodies. Diagnosis requires use within an accepted treponemal/nontreponemal testing algorithm.
Technical Specifications
Antibody Information
| Parameter | Specification |
|---|---|
| Target | TP15/17/47 |
| Technology Platform | Chemiluminescence |
| Application Tags | ALG;INF |
| Storage | 2~ 8℃; -25~ -10℃ |
| Shelf Life | 2年 |
| Sample Pack | 1mg |
Target
TP15/17/47
Technology Platform
Chemiluminescence
Application Tags
ALG;INF
Storage
2~ 8℃; -25~ -10℃
Shelf Life
2年
Sample Pack
1mg
Technical Resources
Product datasheets, quality certificates and related technical documentation are available upon request from our technical team.
Need to confirm the right product or material for your project?
Our technical team can assist with product selection, provide samples, and support your IVD development project.





